As sulfonilureias orais, como glimepirida, glibenclamida e tolazamida, ativam o pâncreas para produzir mais insulina.
Data da revisão:
6/28/2011
Revisão feita por:
Ari S. Eckman, MD, Chief, Division of Endocrinology, Diabetes and Metabolism, Trinitas Regional Medical Center, Elizabeth, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.